Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Gefitinib is superior to carboplatin-paclitaxel as an initial treatment for pulmonary adenocarcinoma among nonsmokers or former light smokers in East Asia. The presence in the t...
Publications
View AllMulticentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)
The purpose of this study was to evaluate the efficacy of gefitinib and the feasibility of screening for epidermal growth factor receptor (EGFR) mutations among select patients ...
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- JP
- Publications
- 2
- Citations
- 8,315
External Links
Identifiers
- ROR
- https://ror.org/00mce9b34